Bandingkan Harga & Kinerja Ciputra Development Tbk (CTRA) vs UBC Medical Indonesia Tbk. (LABS)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Ciputra Development Tbk dan UBC Medical Indonesia Tbk.: Ciputra Development Tbk diperdagangkan di Rp560 (kapitalisasi pasar 10,29 T, volume 24 jam 11,27 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp146 (kapitalisasi pasar 584,6 M, volume 24 jam 817,3 rb). Perbedaan utamanya: Ciputra Development Tbk jauh lebih besar — sekitar 17,6× kapitalisasi pasar UBC Medical Indonesia Tbk., dan Ciputra Development Tbk lebih aktif diperdagangkan (11,27 jt vs 817,3 rb). Mana yang lebih baik tergantung tujuan investasimu.
| CTRA | LABS | |
|---|---|---|
Kapitalisasi Pasar | 10,29 T | 584,6 M |
Volume | 11,27 jt | 817,3 rb |
Lot | 112,75 rb | 8,17 rb |
Perputaran | 6,32 M | 120,01 jt |
Harga Rata-rata | 560,45 | 146,84 |
Nilai Transaksi | 6,32 M | 120,01 jt |
Harga Ekuilibrium Indikatif | 560 | 146 |
Volume Ekuilibrium Indikatif | 3,05 rb | 59 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Ciputra Development Tbk
PT Ciputra Development Tbk (the Company) was established in the Republic of Indonesia originally under the name PT Citra Habitat Indonesia based on notarial deed No. 22 dated October 22, 1981. Ciputra Developments main interest is in residential and township developments which account for approximately 90% of the companies total sales. The company has nine flagship development projects.
Selengkapnya di halaman CTRA →Tentang UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →
